Philosophy & Strategy

Top Message

Left: Hirokazu Ogino,  President and CEO Right: Takashi Tamura,  Representative Director, Exective Operating Officer Left: Hirokazu Ogino, Representative Director, President and CEO
Right: Takashi Tamura, Representative Director, Exective Operating Officer

First we would like to sincerely thank our shareholders for your continued support.

We hereby report the results for FY2019 ended March 31, 2020.

In FY2019, both overall sales and operating income increased compared to the previous fiscal year. In Japan, the last-minute increase in demand preceding the consumption tax increase in October 2019 was mostly offset by a corresponding decrease in the 2nd half of the fiscal year. The Company’s initiative to strengthen its marketing and service capabilities creating customer value also contributed to increased sales. Internationally, supported by steady demand for medical equipment, the Company achieved certain results in strengthening R&D, marketing and service capabilities in the U.S.

The theme for FY2020 is Integration and Unification. Under its new functional organizational structure, the Company will maximize its potential and capabilities, and focus on issues that remained to be solved in the previous mid-term business plan, TRANSFORM 2020. The Company is currently working on ramping up production of ventilators and patient monitors to meet increased demand around the world due to the growing number of COVID-19 patients. In this way, the Company is fulfilling its responsibility to supply products and services and contributing to the resolution of global medical issues. On the other hand, the effect of infection containment measures on economic activity have led to heightened uncertainty in the global economy. The Company will implement the necessary business continuity measures to protect the continuity of our business and employment, even in a challenging environment where there is a real fear of the first global economic crisis since the financial crisis of 2007-2008.

The full-year dividend for FY2019 was 35 yen per share, in which the interim and the year-end dividends were 17 yen and 18 yen per share. We deeply appreciate your continued support.